Glucose Baxter (Glucose)

Glucose Baxter is used in clinical settings primarily as an intravenous carbohydrate source and as an excipient in various formulations.

• To treat or prevent hypoglycemia during surgery or critical care.
• As part of parenteral nutrition solutions providing caloric support.
• As a diluent for intravenous drug admixtures to achieve desired concentration.
• For intravenous glucose tolerance testing and other diagnostic procedures.
• To adjust osmolarity of IV fluids in pediatric or neonatal care.
• For rehydration protocols where glucose contributes to fluid balance and energy provision.
• As a carrier for certain intravenous vitamins and trace elements to improve stability.

Intravenous administration of glucose may be associated with a range of physiological responses, most of which are mild and transient, while rare serious reactions can occur.

Common

• Transient hyperglycemia that resolves with metabolic clearance.
• Mild nausea or vomiting.
• Local irritation or discomfort at the infusion site.
• Temporary electrolyte shifts, such as mild hyponatremia.
• Mild headache or dizziness during infusion.
• Transient increase in serum triglycerides.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypoglycemia after rapid infusion cessation in susceptible patients.
• Allergic reactions, including urticaria or anaphylaxis.
• Volume overload in patients with compromised cardiac function.
• Metabolic acidosis in patients receiving large glucose loads.
• Renal impairment due to osmotic nephrosis with excessive dosing.

When using Glucose Baxter intravenously, healthcare professionals should observe several precautionary measures to ensure patient safety and optimal therapeutic outcomes.

• Verify patient’s blood glucose level before initiating infusion.
• Adjust infusion rate in patients with diabetes or impaired glucose tolerance.
• Monitor electrolytes, especially sodium and potassium, during and after administration.
• Use caution in patients with renal or hepatic dysfunction.
• Avoid rapid large-volume infusions in individuals with heart failure.
• Ensure aseptic technique to prevent catheter‑related infections.
• Document total glucose administered in the patient’s medical record.
• Consider compatibility with other IV medications to prevent precipitation.

Glucose Baxter may interact with certain medications or clinical conditions; awareness of these interactions helps prevent adverse outcomes.

Avoid

• Co‑administration with high‑dose insulin infusions without glucose monitoring.
• Simultaneous infusion of hyperosmolar agents that may exacerbate fluid shifts.
• Avoid mixing with calcium-containing solutions that can precipitate.

Use with caution

• Concurrent use of diuretics, which can alter electrolyte balance.
• Administration alongside catecholamines, as they may affect glucose metabolism.
• Use with nephrotoxic drugs in patients receiving large glucose volumes.
• Combination with blood products that contain citrate, requiring monitoring of calcium levels.
• Caution when used with beta‑blockers, as they may mask hypoglycemia symptoms.